Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$6,764,083
+$770,059 QoQ
Shares Held
26,880
-2.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
2.83%
of 13F equity value
Holder Rank
#1,131
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SCHULHOFF & CO INC holds $28,075,111 across 8 Drug Manufacturers - General names. ABBV ranks #2 (24.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
40,998 | $10,412,262 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
26,880 | $6,764,083 | |
| 3 | LLY |
ELI LILLY & Co
|
4,825 | $5,787,250 | |
| 4 | MRK |
Merck & Co., Inc.
|
12,263 | $1,575,795 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
20,914 | $1,205,064 | |
| 6 | PFE |
Pfizer Inc
|
45,453 | $1,094,508 | |
| 7 | NVS |
Novartis AG
|
6,053 | $948,626 | |
| 8 | AMGN |
Amgen Inc
|
794 | $287,523 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,764,083 | 26,880 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $5,994,024 | 27,560 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $6,329,173 | 27,700 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $6,420,604 | 27,730 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $5,154,853 | 27,771 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $5,791,342 | 27,641 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $4,923,711 | 27,708 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $5,493,498 | 27,818 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $4,785,922 | 27,903 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $5,081,136 | 27,903 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $4,375,268 | 28,233 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $4,227,043 | 28,358 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $4,257,198 | 31,598 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $5,093,146 | 31,958 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $5,172,812 | 32,008 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $4,349,477 | 32,408 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $5,009,557 | 32,708 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $5,307,157 | 32,738 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $4,486,885 | 33,138 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $3,553,022 | 32,938 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $3,671,838 | 32,598 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $3,397,891 | 31,398 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $3,048,203 | 28,448 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $2,401,104 | 27,413 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $2,652,136 | 27,013 | Shares | Sole | 2020-07-29 | |
| 2020-03-31 | $2,050,958 | 26,919 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||